Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

La., said the Senate Health, Education, Labor and Pensions Committee should also increase gig worker access to portable ...

Barnes Drug Store is an independent pharmacy in the south Georgia town of Valdosta that's been serving the community for a ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The City of Greensboro, North Carolina, which provides public safety, emergency, and health services to over 300,000 residents and spends millions annually on insulin medications, filed a lawsuit last ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

'The IRA's drug price controls are already hindering investment in critical drug research and development, undermining the innovation that has long made the U.S. a global leader in biopharmaceutical ...

On his first day in office, President Donald Trump signed multiple executive orders and even rescinded one from his predecessor, President Joe Biden, that planned to lower prescription drug costs.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.